Jenning V, Lippacher A, Gohla S H
Department of Pharmacy, Biopharmaceutics and Biotechnology, Freie Universität Berlin, Germany.
J Microencapsul. 2002 Jan-Feb;19(1):1-10. doi: 10.1080/713817583.
Solid lipid nanoparticles (SLN) were produced by high pressure homogenization using piston-gap homogenizers. Batch sizes varied between 40 ml and 50 l. Because of the different batch sizes, different homogenizer types were used, but the same functional principles were maintained, and the change from 40 ml to 50 l was not critical. With increasing batch sizes, the product quality in terms of particle size distribution and physical storage stability improved. Medium scale (30 l and 50 l) drug-free and drug-loaded SLN batches could be produced reproducibly and batch-to-batch uniformity was proven: within one batch particle sizes were homogeneous. This study revealed the influence of pressure and temperature for the hot homogenization technique A change of pressure between 300-500 bars induced only minor differences in particle size, but some influence of the heating temperature was found. More important than control of the heating process was the control of the cooling process of the final product. A too rapid cooling deteriorated the product quality: cooling with water of 18 degrees C proved to be the optimum cooling condition.
采用活塞间隙均质机通过高压均质法制备了固体脂质纳米粒(SLN)。批次规模在40毫升至50升之间变化。由于批次规模不同,使用了不同类型的均质机,但保持了相同的功能原理,从40毫升到50升的变化并不关键。随着批次规模的增加,产品在粒度分布和物理储存稳定性方面的质量得到了提高。中规模(30升和50升)的无药和载药SLN批次能够可重复生产,并且证明了批次间的一致性:在一批产品中,粒度是均匀的。本研究揭示了热均质技术中压力和温度的影响。300 - 500巴之间的压力变化仅导致粒度有微小差异,但发现加热温度有一定影响。比控制加热过程更重要的是控制最终产品的冷却过程。冷却速度过快会使产品质量下降:用18摄氏度的水冷却被证明是最佳冷却条件。